Evidence map›Paper›PMID 24580763›Full record

ArticleSeminars in perinatology2014

Update on PPHN: mechanisms and treatment.

Jayasree Nair, Satyan Lakshminrusimha

Abstract read
In one paragraph

Article in Seminars in perinatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 3 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 3 syntheses or guidelines pooled it, 213 citations in OpenAlex.

  1. Meconium-stained amniotic fluid.American journal of obstetrics and gynecology · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Pathophysiology and Prevention of Manual-Ventilation-Induced Lung Injury (MVILI).Pathophysiology : the official journal of the International Society for Pathophysiology · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jayasree NairCenter for Developmental Biology of the Lung, State University of New York, Buffalo, NY.
Satyan LakshminrusimhaCenter for Developmental Biology of the Lung, State University of New York, Buffalo, NY; Division of Neonatology, Department of Pediatrics, Women and Children's Hospital of Buffalo, 219 Bryant St, Buffalo, NY 14222. Electronic address: slakshmi@buffalo.edu.
University at Buffalo, State University of New York · USWomen & Children's Hospital of Buffalo · US

Funding

Optimal Oxygenation in Neonatal Lung InjuryR01HD072929 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Satyanarayana Lakshminrusimha · 2012 to 2026
$5.4M
NICHD NIH HHS R01 HD072929
6 · The paper itself

Abstract

Persistent pulmonary hypertension of the newborn (PPHN) is a syndrome of failed circulatory adaptation at birth, seen in about 2/1000 live born infants. While it is mostly seen in term and near-term infants, it can be recognized in some premature infants with respiratory distress or bronchopulmonary dysplasia. Most commonly, PPHN is secondary to delayed or impaired relaxation of the pulmonary vasculature associated with diverse neonatal pulmonary pathologies, such as meconium aspiration syndrome, congenital diaphragmatic hernia, and respiratory distress syndrome. Gentle ventilation strategies, lung recruitment, inhaled nitric oxide, and surfactant therapy have improved outcome and reduced the need for extracorporeal membrane oxygenation (ECMO) in PPHN. Newer modalities of treatment discussed in this article include systemic and inhaled vasodilators like sildenafil, prostaglandin E1, prostacyclin, and endothelin antagonists. With prompt recognition/treatment and early referral to ECMO centers, the mortality rate for PPHN has significantly decreased. However, the risk of potential neurodevelopmental impairment warrants close follow-up after discharge for infants with PPHN.

Indexed as

Administration, InhalationAlprostadilAsphyxia NeonatorumEndothelium-Dependent Relaxing FactorsEpoprostenolExtracorporeal Membrane OxygenationHernia, DiaphragmaticHernias, Diaphragmatic, CongenitalHumansInfant, NewbornMeconium Aspiration SyndromeNitric OxideOxygen Inhalation TherapyPersistent Fetal Circulation SyndromePiperazinesPulmonary SurfactantsAlprostadilEndothelium-Dependent Relaxing FactorsEpoprostenolNitric OxidePiperazinesPulmonary SurfactantsPurinesSildenafil CitrateSulfonesVasodilator AgentsHypoxic respiratory failureNitric oxidePersistent fetal circulationPulmonary vascular resistanceSystemic vasodilators

Identifiers

PMID24580763
PMCPMC3942674
OpenAlexW2170729464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.